Hydrogels for cell therapy
US12421327B2 · kind B2 · utility
0Cited by
2References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 2022 |
| Grant date | Sep 23, 2025 |
| Priority date | — |
| Expiry date | Feb 18, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08B37/00
- WIPO fieldMacromolecular chemistry, polymers
- WIPO sectorChemistry
Abstract
A crosslinked dextran polymer, bearing carboxylate groups, wherein at least two saccharidic units of dextran belonging to two different polymer chains are covalently linked by at least one at least divalent radical, this at least divalent radical being a linear, branched or cyclic alkyl radical including at least 15 carbon atoms and optionally heteroatoms such as oxygen, nitrogen or sulfur.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.